Lv1
80 积分 2024-10-29 加入
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis
8天前
已完结
Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis
8天前
已完结
Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study
21天前
已完结
Safety and Efficacy of Direct Oral Anticoagulants in Patients With Moderate to Severe Cirrhosis
21天前
已完结
The Liver Meeting: Boston, Massachusetts Nov 10-14, 2023
21天前
已完结
Thrombin generation in patients with cirrhosis: The role of platelets
1个月前
已完结
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis
2个月前
已完结
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡
2个月前
已完结
Hypercoagulability in cirrhosis: causes and consequences
2个月前
已完结
The fibrinolytic system in disease: From molecular pathways to clinical outcomes
2个月前
已完结
皖公网安备34019202002308
